Long-term stability of recombinant tissue plasminogen activator at -80 C

BACKGROUND: Recombinant tissue plasminogen activator (tPA) is a thrombolytic widely used clinically in the treatment of acute thrombotic disease such as ischemic stroke, myocardial infarction, and deep venous thrombosis. This has led to much interest in tPA based lytic therapies leading to laborator...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, George J, Sperling, Matthew, Meunier, Jason M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711093/
https://www.ncbi.nlm.nih.gov/pubmed/19566947
http://dx.doi.org/10.1186/1756-0500-2-117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711093/
https://www.ncbi.nlm.nih.gov/pubmed/19566947
http://dx.doi.org/10.1186/1756-0500-2-117

Ejemplares similares